The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Explore trends before investing – request a sample report today! The Non-NGS Predictive Cancer Diagnostics Market is ...
The global multiplex PCR kit market size was valued at USD 1.25 billion in 2024 and is predicted to hit around USD 3.43 ...
The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...
Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...
The company doesn't seem like it will generate pops in key fundamentals anytime soon. Bio-Rad's Q3 saw the company book $653 million in revenue, which was very modestly (0.5%) higher on a ...
Jonathan DiVincenzo, President & COO, reported that "revenue was consistent with our outlook and operating margin exceeded consensus, a testament to the discipline and agility of our teams in what ...
Biodesix, Inc., a leading diagnostics solutions company, announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...
Bio-Rad Laboratories (BIO) has expanded its collaboration with Biodesix, aiming to clinically validate and pursue regulatory approval for cancer biomarker diagnostic assays. The partnership highlights ...
LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...
Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology ...
HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz ...